Diabetic embryopathy

Diabetic embryopathy (also known as diabetic fetopathy, infants of diabetic mothers syndrome, or maternal diabetes-related birth defects) is a spectrum of congenital malformations and complications that occur in infants born to mothers with pre-gestational diabetes mellitus (type 1 or type 2). The condition results from the teratogenic effects of maternal hyperglycemia and associated metabolic disturbances (such as hyperketonemia and oxidative stress) on the developing embryo, particularly during the critical period of organogenesis in the first trimester of pregnancy. Diabetic embryopathy can affect multiple organ systems. The most commonly involved systems include the cardiovascular system (congenital heart defects such as ventricular septal defects, transposition of the great arteries, and conotruncal anomalies), the central nervous system (neural tube defects including anencephaly and spina bifida), the musculoskeletal system (caudal regression syndrome or sacral agenesis, which is highly characteristic of this condition), the genitourinary system (renal agenesis, hydronephrosis), and the gastrointestinal system (small left colon syndrome, duodenal atresia). Macrosomia, neonatal hypoglycemia, hyperbilirubinemia, polycythemia, and respiratory distress syndrome are also frequently observed in affected neonates. There is no specific cure for diabetic embryopathy once malformations have occurred; management is supportive and depends on the specific anomalies present, often requiring surgical correction of structural defects and neonatal intensive care for metabolic complications. The most effective strategy is prevention through strict glycemic control before conception and during early pregnancy. Preconception counseling, optimization of maternal blood glucose levels (ideally achieving a hemoglobin A1c below 6.5% before conception), and close monitoring throughout pregnancy significantly reduce the risk of congenital malformations in pregnancies complicated by diabetes.

Common questions about Diabetic embryopathy